DexCom Inc (DXCM)
68.99
-0.71
(-1.02%)
USD |
NASDAQ |
Nov 05, 16:00
69.02
+0.03
(+0.04%)
After-Hours: 18:22
DexCom Debt to Equity Ratio: 1.233 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.233 |
| June 30, 2024 | 1.001 |
| March 31, 2024 | 1.084 |
| December 31, 2023 | 1.177 |
| September 30, 2023 | 1.127 |
| June 30, 2023 | 1.526 |
| March 31, 2023 | 0.883 |
| December 31, 2022 | 0.9242 |
| September 30, 2022 | 1.079 |
| June 30, 2022 | 0.8721 |
| March 31, 2022 | 0.898 |
| December 31, 2021 | 0.9705 |
| September 30, 2021 | 0.7975 |
| June 30, 2021 | 0.8564 |
| March 31, 2021 | 0.8873 |
| December 31, 2020 | 0.9128 |
| September 30, 2020 | 1.098 |
| June 30, 2020 | 1.225 |
| March 31, 2020 | 1.148 |
| December 31, 2019 | 1.201 |
| September 30, 2019 | 1.37 |
| June 30, 2019 | 1.503 |
| March 31, 2019 | 1.529 |
| December 31, 2018 | 1.523 |
| September 30, 2018 | 0.6026 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.6949 |
| March 31, 2018 | 0.7856 |
| December 31, 2017 | 0.7811 |
| September 30, 2017 | 0.8438 |
| June 30, 2017 | 0.9061 |
| March 31, 2017 | 0.27 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.0074 |
| December 31, 2015 | 0.0104 |
| September 30, 2015 | 0.015 |
| June 30, 2015 | 0.0205 |
| March 31, 2015 | 0.0276 |
| December 31, 2014 | 0.0328 |
| September 30, 2014 | 0.0452 |
| June 30, 2014 | 0.0582 |
| March 31, 2014 | 0.07 |
| December 31, 2013 | 0.0809 |
| September 30, 2013 | 0.0937 |
| June 30, 2013 | 0.0968 |
| March 31, 2013 | 0.0951 |
| December 31, 2012 | 0.0909 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.7975
Minimum
Sep 2021
1.526
Maximum
Jun 2023
1.045
Average
1.040
Median
Debt to Equity Ratio Benchmarks
| Orthofix Medical Inc | 0.2161 |
| Abbott Laboratories | 0.3764 |
| Bristol-Myers Squibb Co | 2.902 |
| Edwards Lifesciences Corp | 0.0803 |
| Tandem Diabetes Care Inc | 1.488 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.354B |
| Total Liabilities (Quarterly) | 4.375B |
| Shareholders Equity (Quarterly) | 1.979B |
| Current Ratio | 2.458 |
| Net Debt Paydown Yield | 0.58% |